Silver Book Fact

Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placebo
by 40% to 55%.

ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group. Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction. Lancet. 1994; 343(8896): 499-503. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2894%2991458-3/abstract

Reference

Title
Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction
Publication
Lancet
Publication Date
1994
Authors
ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group
Volume & Issue
Volume 343, Issue 8896
Pages
499-503
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The use of antioxidant vitamins and other new therapies for age-related macular degeneration (AMD) could reduce visual impairment and blindness from the disease by 35%.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Prescription eye drops could delay or prevent half of glaucoma cases in African Americans.  
  • The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).